Back to search
FDAFDA · Food and drugs·Recall number D-298-2013

GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21.

Published May 1, 2013 · Recall initiated: April 19, 2013

Summary

FDA records drug Class II recall D-298-2013, published May 1, 2013 and initiated April 19, 2013. Recalling firm: Qualitest Pharmaceuticals; Status: Terminated; Reported quantity: 10,373 bottles; Lot: Lot #: C0671212A, Exp 12/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Qualitest Pharmaceuticals
Distributor
Nationwide
Lot
Lot #: C0671212A, Exp 12/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GLIMEPIRIDE TABLETS USP, 2 mg, 100-count tablets per bottle, Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-3745-21. recalled?

Yes. FDA published recall D-298-2013 on May 1, 2013. Reported hazard: Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.

What should I do if I have this product?

Voluntary: Firm initiated · Letter